SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-06-242136
Filing Date
2006-11-27
Accepted
2006-11-27 17:16:51
Documents
7
Period of Report
2006-11-20
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 17207
2 FORM OF UNDERWRITING AGREEMENT dex1a.htm EX-1.A 134803
3 FORM OF FOURTH SUPPLEMENTAL INDENTURE dex4r.htm EX-4.R 50095
4 FORM OF 5.875% NOTES DUE 2036 dex4s.htm EX-4.S 41294
5 FORM OF 4.375% NOTES DUE 2016 dex4t.htm EX-4.T 86721
6 FORM OF 4.625% NOTES DUE 2021 dex4u.htm EX-4.U 86716
7 FORM OF SUBSCRIPTION AGREEMENT dex991.htm EX-99.1 155752
  Complete submission text file 0001193125-06-242136.txt   574266
Mailing Address 345 PARK AVE NEW YORK NY 10154
Business Address 345 PARK AVE NEW YORK NY 10154 2125464000
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01136 | Film No.: 061240089
SIC: 2834 Pharmaceutical Preparations